Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Adial Pharmaceuticals, Inc. (ADIL) had Income from Continuous Operations of $-1.79M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-1.79M |
|
-- |
|
-- |
|
$1.76M |
|
$-1.76M |
|
$-0.03M |
|
$-1.79M |
|
$-1.79M |
|
$-1.79M |
|
|
Income from Continuous Operations |
$-1.79M |
$-1.79M |
|
$-1.79M |
|
$-1.76M |
|
$-1.76M |
|
22.17M |
|
22.17M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$5.01M |
|
-- |
|
$0.65M |
|
$5.66M |
|
$1.15M |
|
-- |
|
-- |
|
$1.15M |
|
$4.51M |
|
$4.50M |
|
$4.51M |
|
23.84M |
|
| Cash Flow Statement Financials | |
$-5.17M |
|
$0.15M |
|
$5.87M |
|
$3.75M |
|
$4.61M |
|
$0.86M |
|
$0.51M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.17M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-39.81% |
|
-39.84% |
|
-31.69% |
|
-39.81% |
|
$0.19 |
|
$-0.23 |
|
$-0.23 |
|